Summary
Progressive dementia syndromes in adults are caused by a number of conditions associated with different structural lesions of the brain. In most clinical and autopsy series, senile dementia of the Alzheimer type is the most common cause of mental decline in the elderly accounting for up to 90%, whereas degenerative non-Alzheimer dementias range from 7 to 30% (mean 8–10%). They include a variety of disorders featured morphologically by neuron and synapse loss and gliosis, often associated with cytopathological changes involving specific cortical and subcortical circuits. These neuronal/ glial inclusions and neuritic alterations show characteristic immunoreactions and ultrastructure indicating cytoskeletal mismetabolism. They are important diagnostic sign posts that, in addition to the distribution pattern of degenerative changes, indicate specific vulnerability of neuronal populations, but their pathogenic role and contribution to mental decline are still poorely understood. In some degenerative disorders no such cytopathological hallmarks have been observed; a small number is genetically determined. While in Alzheimer’s disease (AD) mental decline is mainly related to synaptic and neuritic pathologies, other degenerative disorders show variable substrates of dementia involving different cortical and/or subcortical circuits which may or may not be superimposed by cortical Alzheimer lesions. In most demented patients with Lewy body disorders (Parkinson’s disease, Lewy body dementia), they show similar distribution as in AD, while in Progressive Supranuclear Palsy (PSP), mainly prefrontal areas are involved. Lobar atrophies, increasingly apparent as causes of dementia, show fronto-temporal cortical neuron loss, spongiosis and gliosis with or without neuronal inclusions (Pick bodies) and ballooned cells, while dementing motor neuron disease and multisystem atrophies reveal ubiquitinated neuronal and oligodendroglial inclusions. There are overlaps or suggested relationships between some neurodegenerative disorders, e.g. between corticobasal degeneration, PSP and Pick’s atrophy. In many of these disorders with involvement of the basal ganglia, degeneration of striatofrontal and hippocampo-cortical loops are important factors of mental decline which may be associated with isocortical neuronal degeneration and synapse loss or are superimposed by cortical AD pathology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrew SE, Hayden MR (1995) Origins and evolution of Huntington’s disease chromosomes. Neurodegeneration 4: 239–244
Arima K, Muramaya S, Oyanagi S, Akashi S, Inose T (1992) Presenile dementia with progressive supranuclear palsy tangles and Pick bodies. An unusual degenerative disorder involving the cerebral cortex, cerebral nuclei, and brain stem nuclei. Acta Neuropathol 84: 128–134
Arima K, Uesugi H, Fujita I, Oyanagi S, Andoh S, Izumiyama Y, Inose T (1994) Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: ultrastructural and immunocytochemical studies. J Neurol Sci 127: 186–192
Arnold SE, Kumar A (1993) Reversible dementias. Med Clin North Am 77: 215–230
Arriagada PV, Growdon JH, Hedley-Whyte T, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42: 631–639
Bancher C, Braak H, Fischer P, Jellinger K (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer’s and Parkinson’s disease. Neurosci Lett 162: 179–182
Bancher C, Jellinger KA (1994) Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathol 88: 565–570
Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F (1996) Correlations between mental state and quantitative neuropathology in the Vienna longitudinal study on dementia. Eur Arch Psychiat Clin Neurosci 246: 137–146
Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KL (1995a) Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits. J Neurochem 64: 749–760
Bierer LM, Hof PR, Purohit DP, Carlin L, Schneidler J, Davis KL, Perl DP (1995b) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer’s disease. Arch Neurol 52: 81–88
Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P (1996) Synaptic pathology in Alzheimer’s disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allel. J Neural Transm 103: 603–618
Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 114: 797–811
Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239–259
Braak H, Braak E (1992) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15: 6–31
Braak H, Braak E (1994) Pathology of Alzheimer’s disease. In: Calne DB (ed) Neurodegenerative disease. Saunders, Philadelphia, pp 585–613
Braak H, Braak E, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554–567
Braak H, Braak E, Yilmazer D, De Ros RAI, Jansen ENH, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson’s disesase. Acta Neuropathol 88: 493–500
Braak H, Duyckaerts C, Braak E, Piette F (1993) Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. In: Corain B, et al (eds) Alzheimer’s disease. Advances in clinical and basic research. Wiley, Chichester, pp 131–137
Brandt J, Bylsma FW, Gross R, Stine OC, Ranen N, Ross CA (1996) Trinucleotide repeat length and clincial progression of Huntington’s disease. Neurology 46: 527–531
Brown P (1996) Transmissible human amyloidosis. J Neural Transm [Suppl] 47: 219–229
Brun A, Englund B, Gustayson L, Passant U, Mann DMA, Neary D, Snowdon JS (1994) Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57: 416–418
Brun A, Liu X, Erikson C (1995) Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer’s disease and frontal lobe degeneration. Neurodegeneration 4: 171–177
Budka H, Aguzzi A, Brown P, Brucher J-M, Bugiani O, Gullotta F, Haltia M, Hauw J-J, Ironside JW, Jellinger K, Kretzschmar HA, Lantos PL, Masullo C, Scholte W, Tateishi J, Weller RO (1995) Neuropathological diagnostic criteria for CreutzfeldtJakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5: 459–465
Buée-Scherrer V, Buée L, Hof PR, Leveugle-Giolles C, Loerzel AJ, Perl DP, Delacourte A (1995) Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism dementia complex of Guam: immunochemical characterization of tau proteins. Am J Pathol 68: 924–932
Buée-Scherrer V, Hof PR, Buée L, Leveugle B, et al (1996) Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease. Acta Neuropathol 91: 351–359
Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA (1988) Diffuse Lewy body disease and progressive dementia. Neurology 38: 1520–1528
Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM (1995) Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 58: 167–173
Cooper PN, Jackson M, Lennox G, Lowe J, Mann DMA (1995) Tau, ubiquitin and alpha B crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol 52: 1011–1016
Corey-Bloom J, Thal LJ, Galasko D, Folstein M, et al (1995) Diagnosis and evaluation of dementia. Neurology 45: 211–218
Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L (1988) Clinico-pathological studies in dementia: nondemented subjects with pathologically confirmed Alzheimer’s disease. Neurology 38: 1682–1687
Dababo MA, Bigio EH, Hladik CL, White CL III (1995) Neuropathological evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 54: 429
Daniel SE, De Bruin VMS, Lees AJ (1995) The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Brain 118: 759–770
De Bruin VMS, Lees AJ (1994) Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes. A review of 90 pathologically verified cases. Mov Disord 9: 381–389
De Kosky ST, Harbaugh RE, Schmitt FA, et al (1992) Cortical biopsy in Alzheimer’s disease: diagnostic occuracy and neurochemical. neuropathological and cognitive correlations. Ann Neurol 32: 625–632
Delacourte A, Robitaille Y, Sergeant N, Buée L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gavreau D (1996) Specific pathological tau protein variants characterizing Pick’s disease. J Neuropathol Exp Neurol 55: 159–168
Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16: 285–304
Dickson DW, Feany MB, Yen SH, Matthiace LA, Davies P (1996) Cytoskeletal pathology in non-Alzheimer degenerative dementia. New lesions in Diffuse Lewy body disease, Pick’s disease and Corticobasal Degeneration. J Neural Transm [Suppl] 47: 31–46
Dickson DW, Schmidt ML, Lee VMY, Zhao ML, Yen SH, Trojanowski JQ (1994) Immunoreactivity profile of hippocampal CA2/3 neurites in Diffuse Lewy body disease. Acta Neuropathol 87: 269–276
DSM-III-R (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised. American Psychiatric Association, Washington
Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146: 1388–1396
Feany MB, Ksiezak-Reding H, Liu W-K, et al (1995) Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration; differentiation from progressive supranuclear palsy. Acta Neuropathol 90: 37–43
Feany MB, Mattiace LA, Dickson DW (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease, and corticobasal degeneration. J Neuropathol Exp Neurol 55: 53–67
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”: a practical method grading the cognitive state of patients for the clinician. J Psychiatry Res 12: 189–198
Gai WP, Blessing WW, Blumbergs PC (1995) Ubiquitin-positive degenerating neurites in the brainstem in Parkinson’s disesse. Brain 118: 1447–1459
Gai WP, Blumberg PC, Blessing WW (1996) Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson’s disease. Acta Neuropathol 91: 78–81
Galasko D, Hansen LA, Katzman R, Widerholt W, Masliah E, Terry RD, Hill LR, Lessin P, Thal LJ (1994) Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 51: 888–895
Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A (1995) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 45: 461–466
Gearing M, Olson DA, Watts RL, Mirra SS (1994) Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 44: 1015–1024
Giannokopoulos P, Hof PR, Bours C (1995) Dementia lacking distinctive histopathology. Evaluation of 32 cases. Acta Neuropathol 88: 440–447
Gouider-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y (1995) “Pure” striatonigral degeneration and Parkinson’s disease: a comparative clinical study. Mov Disord 10: 288–294
Haberhausen G, Damian MS, Leweke F, Müller U (1995) Spinocerebellar ataxia type 3 (SCA 3) is genetically identical to Machado-Joseph disease. J Neurol Sci 132: 71–75
Halliday GM, Davies L, McRitchie DA, Cartwright H, Pamphlett R, Morris JGL (1995) Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathol 90: 68–75
Hamada K, Fukazawa T, Yanigihara K, Hamada T, Yoshimura N, Tashiro K (1995) Dementia with ALS features and diffuse Pick body-like inclusions (atypical Pick’s disease?). Clin Neuropathol 14: 1–6
Handler M, Pahwa R, Hubble J, Koller WC (1995) Parkinsonism associated with neurofibrillary tangles and tufted astrocytes (Abstract). Ann Neurol 38: 301
Hanihara T, Amano N, Takahashi T, Nagatomo H, Yagashita S (1995) Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropathol Appl Neurobiol 21: 319–326
Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay RN, Hofstetter R, Klauber M, Rice V, Butters BA, Alford M (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology 40: 1–8
Hansen LA, Masliah E, Galasko D, Terrry RD (1993) Plaque-only Alzheimer disease is usually the Lewy body variant and vice versa. J Neuropathol Exp Neurol 52: 648–654
Harrington CR, Perry RH, Perry EK, Hurt J, McKeith IG, Roth M, Wischik CM (1994a) Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 5: 215–228
Harrington GR, Louwagie J, Rossau R, Van Mechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994b) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types: significance for etiological therories of Alzheimer’s disease. Am J Pathol 145: 1472–1484
Hauw JJ, Daniel S, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for SteeleRichardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015–2019
Hedera P, Lerner AJ, Castellani R, Friedland RP (1995) Concurrence of Alzheimer’s disease, Parkinson’s disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis. J Neurol Sci 128: 219–224
Hedreen JC, Folstein SE (1995) Early loss of neostriatal striosome neurons in Huntington’s disease. J Neuropathol Exp Neurol 54: 105–120
Heinonene O, Soininen H, Sorveri H, Kosunen O, Paljärvi L, Kovisto E, Riekkinen PJ (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer’s disease. Neuroscience 64: 375–384
Heinsen H, Strik M, Bauer M, Luther K, Ulmar G, Gangnus D, Jungkunz G, Eisenmenger W, Gotz N (1994) Cortical and striatal neurone number in Huntington’s disease. Acta Neuropathol 88: 320–333
Higgins JJ, Vascancelos O, Ide SE, Lavendan C, Goldfarb LG, Polymeropoulos MH (1996) Mutations in American families with spinocerebellar ataxia (SCA) type 3; SCA 3 is allelic to Machado-Joseph disease. Neurology 46: 208–213
Hof PR, Bouras C, Perl DP, Morrison H (1994a) Quantitative neuropathologic analysis of Pick’s disease cases: cortical distribution of Pick bodies and coexistance with Alzheimer’s disease. Acta Neuropathol 87: 115–124
Hof PR, Nimchinsky EA, Buée-Scherrer V, Buée L, Nasrallah J, Hottinger AF, Purohit DP, Loerzel AJ, Steele JC, Delacourte A, Bouras C, Morrison JH, Perl DP (1994b) Amyotrophic lateral sclerosis/parkinsonsim-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathol 88: 397–404
Honer WG, Dickson DW, Gleeson J, Davies P (1992) Regional synaptic pathology in Alzheimer’s disease. Neurobiol Aging 13: 375–382
Hoogendijk WJG, Pall CW, Troost D, Venzweiten E, Swaab DF (1995) Image analysis-assisted morphometry of the locus ceruleus in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Brain 118: 131–143
Horoupian DS, Chuy PL (1994) Unusual case of corticobasal degeneration with tau/ Gallyas-positive neuronal and glial tangles. Acta Neuropathol 88: 592–598
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181–184
Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment in Alzheimer disease. Ann Neurol 20: 37–40
Ikeda K, Akiyama H, Kondo H, Haga C (1995) A study of dementia with argyrophilic grains — possible cytoskeletal abnormality in dendrospinal portion of neurons and oligodendroglia. Acta Neuropathol 89: 409–414
Ikeuchi T, Koide R, Tanaka H, Onodera O, et al (1995) Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat. Ann Neurol 37: 769–775
Ince PG, Stade J, Chinnery RM, McKenzie J, Royston C, Roberts GVV, Shaw PJ (1995) Quantitative study of synaptophysin immunoreactivity of cerebral cortex and spinal cord in motor neuron disease. J Neuropathol Exp Neurol 54: 673–679
Insausti R, Tunon T, Sobreviela T, Insausti AM, Gonzalo LM (1995) The human entorhinal cortex. A cytoarchitectonic analysis. J Comp Neurol 355: 171–198
Ironside JW (1996) Human prion diseases. J Neural Transm [Suppl] 47: 231–246
Jackson M, Lowe J (1996) The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 91: 127–134
Jansen ENH, De Vos RAI, Stam FC, Ravid R, Swaab DF (1994) Lewy bodies, with and without dementia: clinico-pathological correlations in 22 consecutive cases of Parkinson’s disease. In: Korczyn AD (ed) Dementia in Parkinson’s disease. Monduzzi Ed, Bologna, pp 207–209
Jellinger K (1987) Neuropathological substrates of Alzheimer’s and Parkinson’s disease. J Neural Transm [Suppl] 24: 109–129
Jellinger KA (1995a) Neurodegenerative disorders with extrapyramidal features. A neuropathological overview. J Neural Transm [Suppl] 46: 33–56
Jellinger KA (1995b) Neuropathological criteria for Pick’s disease and frontotemporal lobe dementia. In: Cruz-Sanchez FF (ed) Neuropathological diagnostic criteria for brain banking. IOS Press, Amsterdam Oxford Washington Tokyo, pp 35–54
Jellinger KA (1996) The neuropathological diagnosis of secondary parkinsonian syndromes. Adv Neurol 69: 293–303
Jellinger KA, Bancher C (1994) Classification of dementias based on functional morphology. In: Jellinger KA, Ladurner G, Windisch E (eds) New trends in the diagnosis and treatment of Alzheimer’s disease. Springer, Wien New York, pp 9–39
Jellinger KA, Bancher C (1995) Structural basis of mental impairment in Parkinson’s disease. Neuropsychiatrie 9: 9–14
Jellinger KA, Bancher C (1996) Dementia with Lewy bodies. Relationship to Parkinson’s and Alzheimer’s disease. In: Perry E, McKeith LG, et al (eds) Dementia with Lewy bodies. Cambridge University Press, New York (in press)
Jellinger K, Bancher C, Fischer P, Lassmann H (1992) Quantitative histopathologic validation of senile dementia of the Alzheimer type. Eur J Gerontol 3: 146–156
Jellinger KA, Bancher C, Fischer P (1993) Neuropathological correlates of mental dysfunctions in Parkinson’s disease. In: Wolters ED, Scheltens P (eds) Mental dysfunction in Parkinson’s disease. Vrije Universiteit, Amsterdam, pp 141–161
Jellinger K, Bancher C, Fischer P, Lassmann H (1994) Staging of degenerative dementia. Neurol Croat 43 [Suppl] 2: 39–58
Jellinger KA, Bancher C, Fischer P (1995) Letter to the editor. J Neuropathol Exp Neurol 54: 129–130
Katzman R, Kawan C (1994) The epidemiology of dementia and Alzheimer disease. In: Terry RD, Katzman R, Bick KI (eds) Alzheimer disease. Raven Press, New York, pp 105–122
Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakmura S, Nishimura M, Akiguchi I, Kimura J, Narumiya S (1994) CAG expansion in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet 8: 221–227.
Kazee AM, Han LY (1995) Cortical Lewy bodies in Alzheimer’s disease. Arch Pathol Lab Med 119: 448–453
Kazee AM, Cox C, Richfield EK (1995) Substantia nigra lesions in Alzheimer disease and normal aging. Alzheimer Dis Assoc Disord 9: 61–67
Kertesz A, Hudson L, Mackenzie JRA, Munoz DG (1994) The pathology and nosology of primary progressive aphasia. Neurology 44: 2065–2072
Khachaturian ZS (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42: 1097–1105
Kim H, Gearing M, Mirra SS (1995) Ubiquitin-positive CA 2(3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 45: 1766–1770
Kosaka K (1993) Dementia and neuropathology in Lewy body disease. Adv Neurol 60: 456–463
Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of various degree — a new disease? Clin Neuropathol 3: 195–192
Kosunen O, Soininen H, Paljärvi L, Heinonen O, Talasniemi S, Riekkinen PJ (1996) Diagnostic accuracy of Alzheimer’s disease: a neuropathological study. Acta Neuropathol 91: 185–193
Ksiezak-Reding H, Morgan K, Mattiace LA, Davies P, Liu WK, Yen SH, Weidenheim K, Dickson DW (1994) Ultrastructural and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 145: 1496–1508
Landwehrmeyer GB, McNeil SMJ, Dure LS, Ge P, et al (1995) Huntington’s disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37: 218–230
Lang AE, Riley DE, Bergeron C (1994a) Cortico-basal ganglionic degeneration. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 877–894
Lang AE, Rogaeva EA, Tsuda T, Hutterer J, Styeorge-Hyslop P (1994b) Homozygous inheritance of the Machado-Joseph disease gene. Ann Neurol 36: 443–447
Lanska DJ, Currier RD, Cohen M, Gambetti P, et al (1994) Familial progressive subcortical gliosis. Neurology 44: 1633–1643
Lantos PL (1992) Neuropathology of unusual dementias; an overview. In: Baillière’s clinical neurology, vol 1. Baillière Tindall, London, pp 485–516
Lamer AJ (1995) The cortical neuritic dystrophy of Alzheimer’s disease: nature, significance, and possible pathogenesis. Dementia 6: 218–224
Lassmann H, Fischer P, Jellinger K (1993) Synaptic pathology of Alzheimer’s disease. Ann NY Acad Sci 695: 59–64
Lassmann H, Weiler R, Fischer P, Bancher C, Jellinger K, Floor E, Danielczyk W, Seitelberger F, Winkler H (1992) Synaptic pathology in Alzheimer’s disease: immunological data for markers of synaptic and large dense core vesicles. Neuroscience 46: 1–8
Lippa CF, Smith IW, Swearer JM (1994) Alzheimer’s disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 35: 81–88
Lippa CF, Smith TW, Saunders AM, et al (1995) Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97–103
Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW (1996a) Validity and reliability of the preliminary NINDS neuropathologic criteria for the diagnosis of progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55: 97–105
Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, D’Olhaberriague L, Anderson DW (1996) Reliability and validity of neuropathology in the diagnosis of neurodegenerative disorders with extrapyramidal features. Neurology 46: 922–930
Markowitsch HJ (1994) Anatomical basis of memory disorders. In: Gazzaniga MS (ed) The cognitive neurosciences. MIT Press, Cambridge, MA, pp 765–781
Martinoli MG, Trojanowski JQ, Schmidt ML, Arnold SE, Fujiwara TM, Yee VM-Y, Hurtig, Julein JP, Clarc C (1995) Association of apolipoprotein e4 allele and neuropathological findings in patients with dementia. Acta Neuropathol 90: 239–243
Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer’s disease. Histol Histopathol 10: 505–519
Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terrry R (1994) Synaptic and neuritic alterations during the progression of Alzheimer’s disease. Neurosci Lett 174: 67–72
McKee AC, Kosik KS, Kowall NW (1992) Neuritic pathology and dementia in Alzheimer’s disease. Ann Neurol 30: 156–165
McKeith IG, Galasko D, Kosaka K, Perry EK, et al (1996) Clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the COLB International Workshop. Neurology (in press)
McKhann GD, Drachmann DA, Folstein MF, et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944
Mirra SS, Hart N, Terry RD (1993) Making the diagnosis of Alzheimer’s disease. A primer for practicing pathologists. Arch Pathol Lab Med 117: 132–144
Mirra SS, Heyman A, McKeef D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479–486
Morris CM, Massey HM, Leake BR, Griffiths BC, Brown LH, Ince GP, et al (1996) Molecular biology of APO E alleles in Alzheimer’s and non-Alzheimer’s dementias. J Neural Transm [Suppl] 47: 205–218
Morris JC, McKeel DW Jr, Storandt M, Rubin EM, Price JL, Grant EA, Ball MJ, Berg L (1991) Very mild Alzheimer’s disease: informant-based clinical, psychometric, and pathological distinction from normal aging. Neurology 41: 469–478
Owen F, Cooper PN, Pickering-Brown S, McAndrew C, Mann DMA, Neary D (1993) The lobar atrophies are non prion encephalopathies. Neurodegeneration 2: 195–199
Papp MI, Lantos PL (1994) The distribution of oligodendroglial inclusions in multiple system atrophy and ist relevance to clinical symptomatology. Brain 117: 235–243
Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith JG, Irving D, Browns A, Perry RH (1995) Alteration in nicotin binding sites in Parkinson’s disease, Lewy body dementia and Alzheimer’s disease: possible index of early neuropathology. Neuroscience 64: 385–395
Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AP, Ince PG, Morris CM, Cheng AV, Perry RM (1993) Cholinergic transmitter and neurotrophic activities in Lewy body dementia. Similarity to Parkinson’s and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 7: 69–79
Petersen RB, Tabaton M, Monari L, Richardson SL, Lynches T, Manetto V, Lanska DJ, Markesberry WR, Currier RD, Autilio-Gambetti L, Wilhelmsen KC, Gambetti P (1995) Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17. Neurology 45: 1062–1067
Pillon B, Blin J, Vidalhet M, Deweer B, Sirigu A, Dubois B, Agid Y (1995) The neuropsychological pattern of corticobasal degeneration — comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology 45: 1477–1483
Pillon B, Deweer B, Malapani C, Rogelet P, Agid Y, Dubois B (1994a) Explicit memory disorders of demented parkinsonian patients and underlying neuronal basis. In: Korczyn AD (ed) Dementia in Parkinson’s disease. Monduzzi Ed, Bologna, pp 265–271
Pillon B, Michon A, Malapani C, Agid Y, Dubois B (1994b) Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer’s, Parkinson’s and Huntington’s diseases. Neurology 44: 1264–1270
Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52: 183–191
Pollanen MS, Weyer L, Bergeron C (1995) Distribution of phosphorylated tau in Pick’s disease, corticobasal degeneration, and frontal lobe dementia (Abstract). J Neuropathol Exp Neurol 54: 446
Roman GC, Tatechimi TK, Erkinjuntti T, et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250–260
Samuel W, Masliah E, Hill LR, Butters N, Terry R (1994a) Hippocampal connectivity and Alzheimer’s dementia. Neurology 44: 2081–2088
Samuel W, Terry RD, DeTeresa R, Butters N, Masliah E (1994b) Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol 51: 772–778
Scheff SW, Price DA (1993) Synapse loss in the temporal lobe in Alzheimer’s disease. Ann Neurol 33: 190–199
Schmitt HP, Yang Y, Forstl H (1995) Frontal lobe degeneration of non-Alzheimer type and Picks atrophy — lumping or splitting. Eur Arch Psychiat Clin Neurosci 245: 299–305
Schneider JA, Gearing M, Watts R, Mirra SS (1995) Corticobasal degeneration: a neuropathological, clinical and molecular study (Abstract). J Neuropathol Exp Neurol 54: 446
Schneider JS, Pope-Coleman A (1995) Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Neurodegeneration 4: 245–255
Scoones D, Ince PG, Shaw PJ, Perry RH (1995) Neuritic pathology in Huntington’s disease is present in the substantia nigra in addition to the cortex: observations in 21 cases, including the rigid variant (Abstract). Neuropathol Appl Neurobiol 21: 445
Sharp AH, Loev SJ, Schilling G, Li SH, et al (1995) Widespread expression of Huntington disease gene (IT15) protein product. Neuron 14: 1065–1074
Skoog I, Nilssen L, Palmertz B, Andreasson LA, Svanborg A (1993) A population-based study of dementia in 85-year olds. N Engl J Med 328: 153–158
Smith MA, Perry G (1994) Is a Lewy body always a Lewy body? In: Korczyn AD (ed) Dementia in Parkinson’s disease. Monduzzi Ed, Bologna, pp 187–193
Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. Arch Neurol 10: 333–359
Takauchi S, Yamauchi S, Morimura Y, Ohara K, Morita Y, Hayashi S, Miyoshi K (1995) Coexistance of Pick bodies and atypical Lewy bodies in the locus ceruleus neurons of Pick’s disease. Acta Neuropathol 90: 93–100
Talbot PR (1996) Frontal lobe dementia and motor neuron disease. J Neural Transm [Suppl] 47: 125–132
Tatemichi TK, Sacktor N, Mayeux R (1994) Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 123–166
Terry RD, Masliah E, Hansen LA (1994) Structural basis of the cognitive alterations in Alzheimer’s disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 179–196
Terry RD, Masliah E, Salomon DP, et al (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572–580
Thompson PD, Day BL, Rothweel JC, Brown P, Britton TC, Marsden CD (1995) The myoclonus in corticobasal degeneration: evidence for two forms of cortical reflex myoclonus. Brain 117;1197–1207
Tierney MC, Fischer H, Lewis AJ, et al (1988) The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: clinicopathological study of 57 cases. Neurology 38: 356–364
Tolnay M, Spillantini M, Goedert M, Probst A (1995) Pick’s disease: somatoaxonal distribution of hyperphosphorylated tau protein (Abstract). Neuropathol App Neurobiol 21: 440
Tolosa E, Duvoisin R, Cruz-Sanchez FF (eds) (1994) Progressive supranuclear palsy: diagnosis, pathology, and therapy. J Neural Transm [Supp142]
Trojanowski JQ, Shin RW, Schmidt ML, Lee VMY (1995) Relationship between plaques, tangles, and dystrophic processes in Alzheimer’s disease. Neurobiol Aging 16: 335–340
Turner RS, Kenyon LC, Trojanowski JQ, Gonatas N, Grossman M (1996) Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Arch Neurol 39: 166–173
Uchihara T, Mitani K, Mori H, Kondo R, Yamada M, Ikeda K (1994) Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer’s disease or progressive supranuclear palsy. Acta Neuropathol 88: 379–383
Uitti RJ, Berry K, Yasuhara O, Eisen A, Feldman H, McGeer PL, Calne DB (1995) Neurodegenerative “overlap” syndrome: clinical and pathological features of Parkinson’s disease, motor neuron disease, and Alzheimer’s disease. Park Rel Dis 1: 21–34
Uyama E, Kondo I, Uchino M, Fukushima T, Murayama N, Kuwano A, Inokuchi N, Ohtam Y, Ando M (1995) Dentatorubral-pallidoluysian atrophy (DRPLA): clinical, genetic, and neuroradiologic studies in a family. J Neurol Sci 130: 146–153
Vermersch P, Robitaille Y, Bernier L, Wattez A, Gavreau D, Delacourte A (1994) Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol 87: 572–577
Vonsattel JP (1992) Neuropathology of Huntington’s disease. In: Joseph AB, Young RR (eds) Movement disorders in neurology and neuropsychiatry. Blackwell Scientific Publications, Oxford London Edinburgh Melbourne Paris Berlin Vienna, pp 186–194
Wakabayashi K, Honer WG, Masliah E (1994) Synapse alterations in the hippocampalentorhinal formation in Alzheimer’s disease with and without Lewy body disease. Brain Res 667: 24–32
Warner TT, Lennox GG, Janota I, Harding AE (1994) Autosomal-dominant dentatorubropallidolysin atrophy in the United Kingdome. Mov Disord 9: 289–296
Warner TT, Williams LD, Walker RWH, Flinter F, Robb SA, Bundey SE, Honavar M, Harding AE (1995) A clinical and molecular genetic study of dentatorubropallidoluysian atrophy in four european families. Ann Neurol 37: 452–459
Watanabe M, Abe K, Aoki M, Kameya T, Kanako J, et al (1996) Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease. J Neurol Sci 136: 101–107
Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SS, Quinn NP (1995) Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 58: 160–166
Wilcock GK, Esiri MM (1982) Plaques, tangles and dementia. A quantitative study. J Neurol Sci 56: 343–356
Williams TL, Shaw PJ, Lowe J, Bates D, Ince PG (1995) Parkinsonism in motor neuron disease: case report and literature review. Acta Neuropathol 89: 275–283
Xuereb JH, Gertz HJ, Huppert F, Brayne C, Wischik CM, Mukaetova-Ladinska E (1995) The application of Braak’s staging model of Alzheimer-type pathology to neuropathological diagnosis of dementia (Abstract). Neuropathol Appl Neurobiol 21: 441
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag
About this paper
Cite this paper
Jellinger, K.A. (1996). Structural basis of dementia in neurodegenerative disorders. In: Jellinger, K.A., Windisch, M. (eds) New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia. Journal of Neural Transmission Supplement, vol 47. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6892-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6892-9_1
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82823-6
Online ISBN: 978-3-7091-6892-9
eBook Packages: Springer Book Archive